IN.PACT Amphirion paclitaxel eluting balloon versus standard percutaneous transluminal angioplasty for infrapopliteal revascularization of critical limb ischemia: Rationale and protocol for an ongoing randomized controlled trial

Trials

Volumn 15, Issue 1, 2014, Pages

  Zeller, Thomas ^a   Baumgartner, Iris ^b   Scheinert, Dierk ^c   Brodmann, Marianne ^d   Bosiers, Marc ^e   Micari, Antonio ^f   Peeters, Patrick ^g   Vermassen, Frank ^h   Landini, Mario ⁱ  

^a UNIVERSITY HEART CENTER FREIBURG BAD KROZINGEN   (Germany)

^b BERN UNIVERSITY HOSPITAL   (Switzerland)

^c Park Hospital Leipzig   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e AZ Sint Blasius ^*  (Belgium)

^f Research Ettore Sansavini Health Science Foundation   (Italy)

^g IMELDA HOSPITAL   (Belgium)

^h GHENT UNIVERSITY HOSPITAL   (Belgium)

ⁱ MEDTRONIC INC   (United States)

Author keywords

Critical limb ischemia; Drug eluting balloon; Infrapopliteal; Peripheral vascular disease

Indexed keywords

ADULT; ADVERSE DEVICE EFFECT; AGED; AMPHIRION PACLITAXEL ELUTING BALLOON; ARTICLE; BARE METAL STENT; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR THERAPEUTIC DEVICE; COHORT ANALYSIS; COMPARATIVE EFFECTIVENESS; CONTROLLED STUDY; CRITICAL LIMB ISCHEMIA; DEVICE SAFETY; DISEASE CLASSIFICATION; DRUG ELUTING STENT; FEMALE; GENERAL CONDITION DETERIORATION; HOSPITALIZATION; HUMAN; INFRAPOPLITEAL REVASCULARIZATION; LEG REVASCULARIZATION; LESION LATE LUMINAL LOSS; MAJOR CLINICAL STUDY; MALE; MEDICAL DEVICE COMPLICATION; MIDDLE AGED; MULTICENTER STUDY; OUTCOME ASSESSMENT; PACLITAXEL ELUTING STENT; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY BALLOON; PROCEDURE RELATED ADVERSE EFFECT; PROCEDURE RELATED SERIOUS ADVERSE EFFECT; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SERIOUS ADVERSE DEVICE EFFECT; SERIOUS ADVERSE EFFECT; SINGLE BLIND PROCEDURE; TARGET LESION REVASCULARIZATION; UNANTICIPATED ADVERSE DEVICE EFFECT; VERY ELDERLY; WOUND HEALING; YOUNG ADULT;

AMPUTATION; ANGIOPLASTY, BALLOON; CARDIOVASCULAR AGENTS; CLINICAL PROTOCOLS; COATED MATERIALS, BIOCOMPATIBLE; CRITICAL ILLNESS; DISABILITY EVALUATION; EQUIPMENT DESIGN; EUROPE; HUMANS; ISCHEMIA; LIMB SALVAGE; LOWER EXTREMITY; PACLITAXEL; PAIN MANAGEMENT; PAIN MEASUREMENT; POPLITEAL ARTERY; PROSPECTIVE STUDIES; QUALITY OF LIFE; RESEARCH DESIGN; SEVERITY OF ILLNESS INDEX; TIME FACTORS; TREATMENT OUTCOME; VASCULAR ACCESS DEVICES; VASCULAR PATENCY; WOUND HEALING;

EID: 84896718849     PISSN: None     EISSN: 17456215     Source Type: Journal    
DOI: 10.1186/1745-6215-15-63     Document Type: Article

References (35)

1. Beard JD. Which is the best revascularization for critical limb ischemia: endovascular or open surgery?. J Vasc Surg 2008, 48:112-116S.
2. Blevins WA, Schneider PA. Endovascular management of critical limb ischemia. Eur J Vasc Endovasc Surg 2010, 39(6):756-761. 10.1016/j.ejvs.2010.02.008, 20299245.
3. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes JF, Fowkes FG, Gillepsie I, Ruckley CV, Raab G, Storkey H. BASIL trial participants. Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicenter, randomised controlled trial. Lancet 2005, 366(9501):1925-1934.
4. Conrad MF, Kang J, Cambria RP, Brewster DC, Watkins MT, Kwolek CJ, LaMuraglia GM. Infrapopliteal balloon angioplasty for the treatment of chronic occlusive disease. J Vasc Surg 2009, 50(4):799-805. 10.1016/j.jvs.2009.05.026, 19786239.
5. Söderström M, Arvela E, Venermo M, Lepäntalo M, Albäck A. Tertiary patency as a measure of active revascularization policy for leg salvage. Ann Vasc Surg 2011, 25(2):159-164. 10.1016/j.avsg.2010.07.018, 20889297.
6. Kudo T, Chandra FA, Ahn SS. The effectiveness of percutaneous transluminal angioplasty for the treatment of critical limb ischemia: a 10-year experience. J Vasc Surg 2005, 41(3):423-435. 10.1016/j.jvs.2004.11.041, 15838475.
7. Haider SN, Kavanagh EG, Forlee M, Colgan MP, Madhavan P, Moore DJ, Shanik GD. Two-year outcome with preferential use of infrainguinal angioplasty for critical ischemia. J Vasc Surg 2006, 43:504-512. 10.1016/j.jvs.2005.11.016, 16520164.
8. Graziani L, Silvestro A, Bertone V, Manara E, Andreini R, Sigala A, Mingardi R, De Giglio R. Vascular involvement in diabetic subjects with ischemic foot ulcer: a new morphologic categorization of disease severity. Eur J Vasc Endovasc Surg 2007, 33(4):453-460. 10.1016/j.ejvs.2006.11.022, 17196848.
9. Parsons RE, Suggs WD, Lee JJ, Sanchez LA, Lyon RT, Veigh FJ. Percutaneous transluminal angioplasty for the treatment of limb threatening ischemia: do the results justify an attempt before bypass grafting?. J Vasc Surg 1998, 28:1066-1071. 10.1016/S0741-5214(98)70033-3, 9845658.
10. Schmidt A, Ulrich M, Winkler B, Klaeffling C, Bausback Y, Bräunlich S, Botsios S, Kruse HJ, Varcoe RL, Kum S, Scheinert D. Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease. Catheter Cardiovasc Interv 2010, 76(7):1047-1054. 10.1002/ccd.22658, 20518006.
11. Baumann F, Willenberg T, Do DD, Keo HH, Baumgartner I, Diehm N. Endovascular revascularization of below-the-knee arteries: prospective short-term angiographic and clinical follow-up. J Vasc Interv Radiol 2011, 22(12):1073-1665.
12. Romiti M, Albers M, Brochado-Neto FC, Durazzo AE, Pereira CA, De Luccia N. Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg 2008, 47(5):975-981. 10.1016/j.jvs.2008.01.005, 18372148.
13. Adam DJ, Bradbury AW. TASC II document on the management of peripheral arterial disease. Eur J Vasc Endovasc Surg 2007, 33(1):1-2. 10.1016/j.ejvs.2006.11.008, 17161778.
14. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, Hiratzka LF, Murphy WR, Olin JW, Puschett JB, Rosenfield KA, Sacks D, Stanley JC, Taylor LM, White CJ, White J, White RA, Antman EM, Smith SC, Adams CD, Anderson JL, Faxon DP, Fuster V, Gibbons RJ, Hunt SA, Jacobs AK, Nishimura R, Ornato JP, Page RL, Riegel B, et al. ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation 2006, 113(11):e463-e654.
15. Conte MS. Diabetic revascularization: endovascular versus open bypass-do we have the answer?. Semin Vasc Surg 2012, 25(2):108-114. 10.1053/j.semvascsurg.2012.04.004, 22817861.
16. Nolan BW, De Martino RR, Stone DH, Schanzer A, Goodney PP, Walsh DW, Cronenwett JL, Vascular Study Group of New England Prior failed ipsilateral percutaneous endovascular intervention in patients with critical limb ischemia predicts poor outcome after lower extremity bypass. J Vasc Surg 2011, 54(3):730-735. 10.1016/j.jvs.2011.03.236, 21802888, Vascular Study Group of New England.
17. Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Bräunlich S, Ick H, Schuster J, Botsios S, Kruse HJ, Varcoe RL, Scheinert D. First experience with drug-eluting balloons in infrapopliteal arteries: restenosis rate and clinical outcome. J Am Coll Cardiol 2011, 58(11):1105-1109. 10.1016/j.jacc.2011.05.034, 21884945.
18. Fanelli F, Cannavale A, Boatta E, Corona M, Lucatelli P, Wlderk A, Cirelli C, Salvatori FM. Lower limb multilevel treatment with drug-eluting balloons: 6-month results from the DEBELLUM randomized trial. J Endovasc Ther 2012, 19(5):571-580. 10.1583/JEVT-12-3926MR.1, 23046320.
19. Liistro F, Porto I, Angioli P, Grotti S, Ricci L, Ducci K, Falsini G, Ventoruzzo G, Turini F, Bellandi G, Bolognese L. Drug-eluting balloon in peripherAl inTErvention for below the knee angioplasty evaluation (DEBATE-BTK): a randomized trial in diabetic patients with critical limb ischemia. Circulation 2013, [Epub ahead of print].
20. Tepe G, Zeller T, Albrecht T, Heller S, Schwarzwälder U, Beregi JP, Claussen CD, Oldenburg A, Scheller B, Speck U. Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg. N Engl J Med 2008, 358(7):689-699. 10.1056/NEJMoa0706356, 18272892.
21. Werk M, Langner S, Reinkensmeier B, Boettcher HF, Tepe G, Dietz U, Hosten N, Hamm B, Speck U, Ricke J. Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial. Circulation 2008, 118(13):1358-1365. 10.1161/CIRCULATIONAHA.107.735985, 18779447.
22. Werk M, Albrecht T, Meyer DR, Ahmed MN, Behne A, Dietz U, Eschenbach G, Hartmann H, Lange C, Schnorr B, Stiepani H, Zoccai GB, Hänninen EL. Paclitaxel-coated balloons reduce restenosis after femoro-popliteal angioplasty: evidence from the randomized PACIFIER trial. Circ Cardiovasc Interv 2012, 5(6):831-840. 10.1161/CIRCINTERVENTIONS.112.971630, 23192918.
23. Micari A, Cioppa A, Vadalà G, Castriota F, Liso A, Marchese A, Grattoni C, Pantaleo P, Cremonesi A, Rubino P, Biamino G. 2-year results of paclitaxel-eluting balloons for femoropopliteal artery disease: evidence from a multicenter registry. JACC Cardiovasc Interv 2013, 6(3):282-289. 10.1016/j.jcin.2013.01.128, 23517840.
24. Taylor G, Palmer J. The vascular territories (angiosomes) of the body: experimental studies and clinical application. Br J Plast Surg 1987, 40:113-141. 10.1016/0007-1226(87)90185-8, 3567445.
25. Iida O, Nanto S, Uematsu M, Ikeoka K, Okamoto S, Dohi T, Fujita M, Terashi H, Nagata S. Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv 2010, 75(6):830-836.
26. Kabra A, Suresh K, Vivekanand V, Vishnu M, Sumanth R, Nekkanti M. Outcomes of angiosome and non-angiosome targeted revascularization in critical lower limb ischemia. J Vasc Surg 2013, 57:44-49. 10.1016/j.jvs.2012.07.042, 23058724.
27. Neville RF, Attinger CE, Bulan EJ, Ducic I, Thomassen M, Sidawy AN. Revascularization of a specific angiosome for limb salvage: does the target artery matter?. Ann Vasc Surg 2009, 23(3):367-373. 10.1016/j.avsg.2008.08.022, 19179041.
28. Peregrin JH, Koznar B, Kovác J, Lastovicková J, Novotný J, Vedlich D, Skibová J. PTA of infrapopliteal arteries: long-term clinical follow-up and analysis of factors influencing clinical outcome. Cardiovasc Intervent Radiol 2010, 33(4):720-725. 10.1007/s00270-010-9881-3, 20458587.
29. Faglia E, Clerici G, Clerissi J, Mantero M, Caminiti M, Quarantiello A, Curci V, Lupattelli T, Morabito A. When is a technically successful peripheral angioplasty effective in preventing above-the-ankle amputation in diabetic patients with critical limb ischaemia?. Diabet Med 2007, 24(8):823-829. 10.1111/j.1464-5491.2007.02167.x, 17559430.
30. Manzi M, Cester G, Palena LM, Alek J, Candeo A, Ferraresi R. Vascular imaging of the foot: the first step toward endovascular recanalization. Radiographics 2011, 31(6):1623-1636. 10.1148/rg.316115511, 21997985.
31. Manzi M, Fusaro M, Ceccacci T, Erente G, Dalla Paola L, Brocco E. Clinical results of below-the knee intervention using pedal-plantar loop technique for the revascularization of foot arteries. J Cardiovasc Surg (Torino) 2009, 50(3):331-337.
32. Utsunomiya M, Nakamura M, Nakanishi M, Takagi T, Hara H, Onishi K, Yamada T, Sugi K. Impact of wound blush as an angiographic end point of endovascular therapy for patients with critical limb ischemia. J Vasc Surg 2012, 55(1):113-1121. 10.1016/j.jvs.2011.08.001, 21943874.
33. Blackwelder W. " Proving the null hypothesis" in clinical trials. Control Clin Trials 1982, 3:345-353. 10.1016/0197-2456(82)90024-1, 7160191.
34. Kelsch B, Scheller B, Biedermann M, Clever YP, Schaffner S, Mahnkopf D, Speck U, Cremers B. Dose response to Paclitaxel-coated balloon catheters in the porcine coronary overstretch and stent implantation model. Invest Radiol 2011, 46(4):255-263. 10.1097/RLI.0b013e31820577df, 21285890.
35. Schnorr B, Kelsch B, Cremers B, Clever YP, Speck U, Scheller B. Paclitaxel-coated balloons - Survey of preclinical data. Minerva Cardioangiol 2010, 58(5):567-582.